ANGPT2 and NOS3 Polymorphisms and Clinical Outcome in Advanced Hepatocellular Carcinoma Patients Receiving Sorafenib

Sorafenib represents the standard of care for advanced hepatocellular carcinoma (HCC), even though a large number of patients have reported limited efficacy. The aim of the present study was to evaluate the prognostic value of single-nucleotide polymorphisms on angiopoietin-2 (ANGPT2) and endothelia...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Marisi, Giorgia, Petracci, Elisabetta, Raimondi, Francesco, Faloppi, Luca, Foschi, Francesco Giuseppe, Lauletta, Gianfranco, Iavarone, Massimo, Canale, Matteo, Valgiusti, Martina, Neri, Luca Maria, Ulivi, Paola, Orsi, Giulia, Rovesti, Giulia, Vukotic, Ranka, Conti, Fabio, Cucchetti, Alessandro, Ercolani, Giorgio, Andrikou, Kalliopi, Cascinu, Stefano, Scartozzi, Mario, Casadei-Gardini, Andrea
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6679015/
https://ncbi.nlm.nih.gov/pubmed/31330833
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11071023
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados